NYXH

Nyxoah is a medical technology company focused on the development and commercialization of solutions to treat obstructive sleep apnea (OSA). Its lead product is the Genio® system, a leadless and battery-free hypoglossal neurostimulation therapy designed for OSA, which is a common sleep disordered breathing condition affecting millions globally. Nyxoah aims to provide treatment options for patients suffering from moderate to severe OSA, which is associated with various health risks.